Examkin

Foundational Science and Mechanisms of Disease

426 questions

All types426Multiple choice221Numeric17Matching95Ordering93
Question 41Question →

A 45-year-old man comes to the clinic for a routine follow-up examination of type 2 diabetes mellitus. His current regimen includes metformin and a newly added oral antihyperglycemic medication, which was started four weeks ago. The patient reports that his home fasting blood glucose readings have improved significantly. However, he has noticed that his shoes feel tighter and he has gained 2.5 kg (5.5 lb) since his last visit. He has a history of mild heart failure with preserved ejection fraction. Physical examination reveals 2+ bilateral pitting edema of the lower extremities. Laboratory studies show a fasting plasma glucose of 112 mg/dL. The physician realizes the new medication is responsible for the patient's fluid retention, which is exacerbating his underlying cardiac condition, and plans to discontinue it immediately. The discontinued drug most likely exerts its primary therapeutic effect by initially binding to which of the following cellular targets?

Show answer & explanation

Answer: Intracellular receptor that heterodimerizes with the retinoid X receptor

Answer

The correct target is an intracellular receptor that heterodimerizes with the retinoid X receptor, which correctly describes the mechanism of action of thiazolidinediones.
The clinical presentation of improved glycemic control accompanied by new-onset weight gain and peripheral edema in a patient with a history of heart failure strongly points to the recent initiation of a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone. TZDs are agonists of the peroxisome proliferator-activated receptor gamma (PPAR-gamma). PPAR-gamma is an intracellular (nuclear) receptor. Upon binding a TZD, PPAR-gamma forms a heterodimer with the retinoid X receptor (RXR). This complex binds to specific DNA response elements to alter the transcription of various genes, ultimately increasing adiponectin levels, promoting adipocyte differentiation, and increasing insulin sensitivity (e.g., via GLUT4 upregulation). A major side effect of TZDs is fluid retention due to increased sodium reabsorption in the renal collecting ducts via upregulation of epithelial sodium channels (ENaC). This fluid retention can precipitate or exacerbate heart failure, making TZDs strictly contraindicated in these patients.

Step-by-Step Solution

1
Analyze the patient's new symptoms following the initiation of an oral antidiabetic drug.
The patient developed significant weight gain and bilateral pitting edema of the lower extremities.
Identifying the specific side effect profile is essential to determining the drug class responsible.
2
Correlate the side effects and the patient's medical history with antidiabetic medication classes.
Thiazolidinediones (e.g., pioglitazone) are known to cause fluid retention and weight gain, and they carry a black box warning for causing or exacerbating heart failure.
This confirms the newly added medication was a thiazolidinedione, explaining the physician's immediate decision to discontinue it.
3
Identify the cellular mechanism of action for thiazolidinediones.
They bind to peroxisome proliferator-activated receptor gamma (PPAR-gamma), an intracellular nuclear receptor.
The question specifically asks for the cellular target of the discontinued medication.
4
Determine the downstream molecular pathway of PPAR-gamma activation.
Upon binding its ligand, PPAR-gamma heterodimerizes with the retinoid X receptor (RXR) to alter the transcription of insulin-responsive genes.
This matches the correct option describing the receptor's specific behavior.

Key Concept

Thiazolidinediones (TZDs) improve insulin sensitivity by binding to PPAR-gamma, an intracellular nuclear receptor that heterodimerizes with the retinoid X receptor (RXR) to regulate the transcription of genes involved in glucose and lipid metabolism. Due to their tendency to increase renal sodium reabsorption leading to fluid retention, TZDs are contraindicated in patients with symptomatic heart failure.
Question 42Question →

Match each patient's clinical presentation of a suspected paraneoplastic syndrome with the most likely underlying neoplastic etiology and its associated pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 65-year-old man with a significant smoking history presents with new-onset proximal muscle weakness that improves with repeated exercise, accompanied by absent deep tendon reflexes.
A 58-year-old woman with a palpable abdominal mass presents with recurrent episodes of facial flushing, frequent watery diarrhea, and a newly detected right-sided heart murmur.
A 70-year-old man with unintentional weight loss and vague abdominal pain develops recurrent, migratory superficial thrombophlebitis affecting multiple extremities.
A 50-year-old woman with a known adnexal mass presents with rapidly progressive cerebellar ataxia, dysarthria, and nystagmus over the past three weeks.

Matches

Show answer & explanation

Answer

Lambert-Eaton syndrome matches with small cell lung carcinoma (presynaptic calcium channel antibodies); Carcinoid syndrome matches with metastatic neuroendocrine tumor (serotonin/vasoactive peptides); Trousseau syndrome matches with pancreatic adenocarcinoma (mucins/tissue factor); Paraneoplastic cerebellar degeneration matches with ovarian/breast carcinoma (anti-Yo antibodies).
Paraneoplastic syndromes represent systemic manifestations of cancer that are not directly caused by the physical mass of the primary tumor or its metastases. Understanding these pathophysiologic connections is essential for early diagnosis and appropriate management. Lambert-Eaton is driven by presynaptic voltage-gated calcium channel antibodies (small cell lung cancer); carcinoid syndrome by serotonin and vasoactive peptides (metastatic neuroendocrine tumors); Trousseau syndrome by tumor-derived procoagulants (pancreatic adenocarcinoma); and paraneoplastic cerebellar degeneration by cross-reacting anti-Yo antibodies (ovarian/breast cancer).

Step-by-Step Solution

1
Evaluate the patient with proximal weakness improving with use and absent reflexes.
Identify Lambert-Eaton myasthenic syndrome.
This presentation points to a defect in presynaptic acetylcholine release due to calcium channel antibodies, typically triggered by small cell lung cancer.
2
Analyze the case of flushing, diarrhea, and right heart murmurs.
Identify carcinoid syndrome.
Systemic release of serotonin from a neuroendocrine tumor that has bypassed hepatic degradation causes these vasomotor and fibrotic symptoms.
3
Assess the presentation of migratory superficial thrombophlebitis.
Identify Trousseau syndrome.
This paraneoplastic hypercoagulability is heavily associated with pancreatic adenocarcinoma releasing mucins and tissue factor.
4
Review the acute cerebellar signs in a patient with an adnexal mass.
Identify paraneoplastic cerebellar degeneration.
The clinical picture strongly correlates with an ovarian malignancy driving an immune response via anti-Yo antibodies against Purkinje cells.

Key Concept

Paraneoplastic syndromes often provide early clinical clues to an underlying malignancy and are mediated by aberrant tumor secretion of hormones, peptides, or cross-reacting autoantibodies.
Question 43Question →

A 46-year-old man comes to the clinic for a follow-up visit regarding poorly controlled hypertension. Over the past 4 months, his blood pressure has consistently been in the 160s/100s mmHg despite adherence to maximum doses of amlodipine and lisinopril. He reports new-onset generalized muscle weakness, fatigue, and frequent urination. His medical history is significant for chronic dyspepsia, for which he recently began consuming large quantities of a European herbal black candy. He does not use tobacco or illicit drugs. Blood pressure is 168/98168/98 mmHg, and pulse is 78/min. Physical examination reveals no edema, normal secondary sexual characteristics, and no striae or easy bruising.

Laboratory studies show:
Serum sodium: 146 mEq/L
Serum potassium: 2.5 mEq/L
Serum chloride: 101 mEq/L
Serum bicarbonate: 32 mEq/L
Plasma renin activity: 0.1 ng/mL/hr (normal: 0.6-4.3 ng/mL/hr)
Plasma aldosterone: 1.2 ng/dL (normal: 3.0-30.0 ng/dL)
Morning serum cortisol: 16 μ\mu g/dL (normal: 5-23 μ\mu g/dL)

Which of the following best describes the specific molecular mechanism responsible for this patient's clinical and laboratory presentation?

Show answer & explanation

Answer: Inhibition of the intracellular conversion of cortisol to its inactive metabolite in the distal nephron

Answer

Inhibition of the intracellular conversion of cortisol to its inactive metabolite in the distal nephron
The correct answer describes the molecular mechanism of acquired apparent mineralocorticoid excess (AME) secondary to licorice ingestion. The patient's presentation of severe hypertension, hypokalemia, and metabolic alkalosis strongly suggests a state of mineralocorticoid excess. However, both plasma renin activity and aldosterone levels are markedly suppressed, eliminating primary and secondary hyperaldosteronism. The crucial historical clue is the patient's consumption of a 'European herbal black candy' for dyspepsia, which points to authentic black licorice. Black licorice contains glycyrrhizic acid, which is hydrolyzed in the gut to glycyrrhetinic acid. In the principal cells of the renal collecting duct, glycyrrhetinic acid competitively inhibits the enzyme 11 β\beta-hydroxysteroid dehydrogenase type 2 (11 β\beta-HSD2). Normally, 11 β\beta-HSD2 rapidly converts cortisol into its inactive metabolite, cortisone. This protects the mineralocorticoid receptor (MR) from cortisol, which circulates at concentrations 100 to 1,000 times higher than aldosterone but has equal affinity for the MR. When 11 β\beta-HSD2 is inhibited, local intracellular cortisol levels rise and inappropriately activate the MR, leading to enhanced sodium reabsorption, potassium excretion, and volume expansion with subsequent suppression of the renin-angiotensin-aldosterone system.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient has severe, treatment-resistant hypertension, profound hypokalemia, and metabolic alkalosis, indicating a state of mineralocorticoid excess.
Recognizing the triad of hypertension, hypokalemia, and alkalosis is the first step in localizing the pathology to the adrenal-renal axis.
2
Evaluate the renin-angiotensin-aldosterone system (RAAS) profile.
Both plasma renin activity and plasma aldosterone are markedly suppressed.
This rules out primary hyperaldosteronism (Conn syndrome - high aldosterone, low renin) and secondary hyperaldosteronism (high renin, high aldosterone).
3
Formulate a differential diagnosis for low-renin, low-aldosterone hypertension.
The differential includes exogenous mineralocorticoid use, Liddle syndrome, congenital adrenal hyperplasia (11 β\beta- or 17 α\alpha-hydroxylase deficiency), Cushing syndrome, and apparent mineralocorticoid excess (AME).
A structured differential prevents premature closure on genetic causes and forces consideration of acquired etiologies.
4
Correlate the medical history with the differential diagnosis.
The recent consumption of 'European herbal black candy' for dyspepsia suggests ingestion of authentic black licorice, which contains glycyrrhizic acid.
Identifying the trigger differentiates an acquired condition from congenital or genetic causes like Liddle syndrome or CAH.
5
Determine the precise molecular mechanism of the offending agent.
Glycyrrhetinic acid (the active metabolite of licorice) competitively inhibits 11 β\beta-hydroxysteroid dehydrogenase type 2 (11 β\beta-HSD2) in the renal collecting duct, preventing the conversion of cortisol to inactive cortisone and allowing cortisol to inappropriately activate the mineralocorticoid receptor.
This establishes the final mechanistic link required to answer the question correctly.

Key Concept

Licorice-induced apparent mineralocorticoid excess (AME) is caused by the inhibition of 11 β\beta-hydroxysteroid dehydrogenase type 2 (11 β\beta-HSD2) in the renal collecting duct, leading to inappropriate activation of the mineralocorticoid receptor by circulating cortisol.
Estimated Time:1m 30s
Question 44Question →

A 22-year-old man presents to the gastroenterology clinic for evaluation of intermittent bright red blood per rectum over the past two months. He reports no abdominal pain, unexplained weight loss, or changes in stool caliber. His father died of metastatic colorectal cancer at age 38, and a paternal aunt underwent abdominal surgery for an unknown malignancy in her 30s. His temperature is 37.0°C (98.6°F), blood pressure is 118/76 mmHg, pulse is 72/min, and respirations are 14/min. Physical examination reveals a soft, non-tender abdomen without organomegaly. Digital rectal examination demonstrates normal sphincter tone with small amounts of bright red blood on the examining finger. Given his striking family history, a colonoscopy is performed and reveals over 150 small adenomatous polyps carpeting the entire colon and rectum. Biopsies of several polyps confirm tubular adenomas with low-grade dysplasia. Which of the following best describes the underlying foundational mechanism of this patient's condition and the most appropriate definitive management?

Show answer & explanation

Answer: Loss-of-function mutation in a gene regulating degradation of beta-catenin; prophylactic proctocolectomy

Answer

The correct option identifies a loss-of-function mutation in a gene regulating degradation of beta-catenin, managed definitively with a prophylactic proctocolectomy.
The correct answer accurately identifies both the molecular pathogenesis of Familial Adenomatous Polyposis (FAP) and its standard definitive management. FAP is caused by a germline loss-of-function mutation in the APC (Adenomatous Polyposis Coli) gene. The APC protein is a critical component of the Wnt signaling pathway, where it normally binds to beta-catenin and marks it for ubiquitination and proteasomal degradation. Without a functional APC protein, beta-catenin accumulates in the cytoplasm, translocates to the nucleus, and continuously activates transcription factors (like TCF/LEF) that promote cellular proliferation. Because patients with FAP develop hundreds to thousands of adenomatous polyps, they carry a nearly 100% lifetime risk of colorectal cancer. Therefore, once widespread polyposis is identified, prophylactic proctocolectomy (often with an ileoanal pouch anastomosis) is indicated to prevent malignant transformation.

Step-by-Step Solution

1
Analyze the clinical presentation and endoscopic findings.
A 22-year-old with a strong early-onset family history and >150 colonic polyps is highly indicative of Familial Adenomatous Polyposis (FAP).
Recognizing the classic phenotype of FAP distinguishes it from other hereditary cancer syndromes like Lynch syndrome, which presents with far fewer polyps.
2
Identify the foundational molecular mechanism of the disease.
FAP is an autosomal dominant condition caused by a germline mutation in the APC tumor suppressor gene.
The normal APC protein complexes with beta-catenin and targets it for degradation. Loss of APC allows beta-catenin to accumulate, enter the nucleus, and drive cellular proliferation.
3
Determine the appropriate long-term definitive management.
Prophylactic proctocolectomy.
Patients with FAP have a nearly 100% lifetime risk of developing colorectal carcinoma, usually by age 40 to 50, making surgical removal of the colon and rectum the standard of care once polyposis is established.

Key Concept

The molecular pathogenesis and clinical management of Familial Adenomatous Polyposis (FAP).
Question 45Question →

A hospital laboratory is reviewing several distinct metabolic profiles of patients with disorders of calcium homeostasis. Match each patient's serum and urine biochemical profile to the most likely underlying pathophysiological mechanism.

Click a left item, then click its matching right item

Items

Elevated serum Ca2+Ca^{2+}, decreased serum PO43−PO_4^{3-}, elevated intact PTH, and elevated 24-hour urinary calcium
Decreased serum Ca2+Ca^{2+}, elevated serum PO43−PO_4^{3-}, elevated intact PTH, and decreased 1,25-dihydroxycholecalciferol
Elevated serum Ca2+Ca^{2+}, high-normal intact PTH, and decreased fractional excretion of calcium (< 1%)
Elevated serum Ca2+Ca^{2+}, high-normal serum PO43−PO_4^{3-}, suppressed intact PTH, and elevated 1,25-dihydroxycholecalciferol
Decreased serum Ca2+Ca^{2+}, elevated serum PO43−PO_4^{3-}, suppressed intact PTH, and decreased 1,25-dihydroxycholecalciferol

Matches

Show answer & explanation

Answer

Profile 1 matches autonomous adenoma; Profile 2 matches impaired renal clearance; Profile 3 matches CaSR mutation; Profile 4 matches ectopic macrophage activity; Profile 5 matches absent parathyroid tissue.
Each laboratory profile uniquely matches a specific pathophysiological lesion. The interplay between calcium, phosphorus, PTH, and vitamin D allows for precise localization of the defect to the parathyroid glands, kidneys, calcium-sensing receptors, or ectopic sources.

Step-by-Step Solution

1
Analyze the parathyroid hormone (PTH) levels relative to the serum calcium levels.
In profiles 1, 3, and 4, hypercalcemia is present. In profiles 2 and 5, hypocalcemia is present.
Determining whether PTH is appropriately suppressed or inappropriately elevated helps distinguish parathyroid-dependent from parathyroid-independent mechanisms.
2
Evaluate hypercalcemic profiles (1, 3, 4).
Profile 1 has high PTH and high urine calcium (Primary hyperparathyroidism). Profile 3 has normal/high PTH and low urine calcium (FHH). Profile 4 has suppressed PTH and high active vitamin D (Granulomatous disease).
Urinary calcium and vitamin D levels differentiate the underlying causes of hypercalcemia.
3
Evaluate hypocalcemic profiles (2, 5).
Profile 2 has elevated PTH (Secondary hyperparathyroidism due to CKD). Profile 5 has suppressed PTH (Primary hypoparathyroidism).
The PTH response defines whether the defect is in the parathyroid glands themselves or due to chronic end-organ dysfunction.

Key Concept

Differential diagnosis of calcium and phosphate homeostasis disorders based on the parathyroid hormone, 1,25-dihydroxyvitamin D, and urinary calcium axes.
Question 46Question →

A 28-year-old woman is admitted to the medical ward with a 3-day history of high fever, marked facial swelling, and a widespread skin eruption. She reports that the rash began on her face and upper trunk before spreading to her extremities. Four weeks ago, she was prescribed sulfasalazine for newly diagnosed inflammatory bowel disease. Her temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, and pulse is 112/min. Physical examination reveals prominent periorbital edema, generalized cervical lymphadenopathy, and a diffuse, confluent, erythematous maculopapular rash covering 70% of her body surface area. There is no mucosal ulceration or epidermal detachment. Laboratory studies show:

Leukocyte count: 18,500/mm318,500/\text{mm}^3
Eosinophils: 2,500/mm32,500/\text{mm}^3 (normal: 15–500/mm315–500/\text{mm}^3)
Alanine aminotransferase (ALT): 450 U/L
Aspartate aminotransferase (AST): 410 U/L
Serum creatinine: 1.1 mg/dL

Which of the following best describes the predominant immunopathologic mechanism driving this patient's clinical syndrome?

Show answer & explanation

Answer: Oligoclonal expansion of T-lymphocytes with subsequent release of interleukin-5

Answer

The correct mechanism is the oligoclonal expansion of T-lymphocytes with subsequent release of interleukin-5, which characterizes DRESS syndrome.
The patient's presentation (a latency period of 4 weeks, prominent facial edema, fever, generalized rash, lymphadenopathy, profound eosinophilia, and hepatic injury) is the classic triad for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome. Sulfasalazine, alongside anticonvulsants and allopurinol, is a notorious trigger. DRESS is classified as a severe, delayed-type (Type IVb) hypersensitivity reaction. The pathogenesis is driven by the oligoclonal expansion of drug-specific T-lymphocytes (predominantly Th2 cells). These T-cells secrete massive amounts of interleukin-5 (IL-5), a cytokine that specifically stimulates eosinophil production, activation, and subsequent infiltration into tissues such as the liver, skin, and heart, resulting in severe end-organ damage.

Step-by-Step Solution

1
Analyze the timeline and clinical presentation.
The patient developed high fever, facial edema, diffuse rash, and lymphadenopathy exactly 4 weeks after starting sulfasalazine.
This specific 2 to 8-week latency period combined with systemic signs and facial edema strongly suggests a delayed-type drug reaction rather than an acute allergy.
2
Evaluate the laboratory findings in the context of the physical exam.
Labs reveal profound peripheral eosinophilia (2,500/mm32,500/\text{mm}^3) and severe transaminitis (ALT 450 U/L), without mucosal ulceration or skin sloughing.
Visceral organ involvement (most commonly hepatic) combined with significant eosinophilia confirms the diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, differentiating it from Stevens-Johnson syndrome (SJS).
3
Identify the underlying immunopathologic mechanism.
DRESS is a Type IVb hypersensitivity reaction.
It is mediated by drug-specific T-cells (primarily Th2 phenotype) that secrete large amounts of interleukin-5 (IL-5), driving the proliferation, activation, and tissue infiltration of eosinophils that cause end-organ damage.

Key Concept

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe Type IVb hypersensitivity reaction mediated by T-cells that secrete IL-5, leading to eosinophilic tissue infiltration and organ damage.
Question 47Question →

A 3232-year-old man comes to the clinic to establish care. He feels well and has no medical problems. He takes no medications. Vital signs are within normal limits. Routine laboratory testing reveals a serum calcium level of 11.211.2 mg/dL (N: 8.48.4-10.210.2 mg/dL) and a serum intact parathyroid hormone level of 5555 pg/mL (N: 1515-6565 pg/mL). A 2424-hour urine collection shows a calcium excretion of 4545 mg/day (N: 100100-300300 mg/day). The urine calcium-to-creatinine clearance ratio is calculated to be 0.0050.005 (normal >0.02>0.02). His mother also has a history of mild, asymptomatic hypercalcemia that was treated with a parathyroidectomy in her 3030 s without resolution of the hypercalcemia. Which of the following best describes the cellular mechanism underlying this patient's laboratory findings?

Show answer & explanation

Answer: Decreased sensitivity of a G protein-coupled receptor to extracellular cations

Answer

Decreased sensitivity of a G protein-coupled receptor to extracellular cations
The correct answer accurately describes the pathophysiology of familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant disorder caused by an inactivating mutation in the calcium-sensing receptor (CaSR) gene. The CaSR is a G protein-coupled receptor located on the chief cells of the parathyroid gland and the basolateral membrane of the thick ascending limb of the loop of Henle. In FHH, the mutated CaSR requires higher concentrations of extracellular calcium to activate its intracellular Gq signaling cascade. This decreased sensitivity raises the set-point for calcium homeostasis, resulting in mild hypercalcemia with an inappropriately normal or slightly elevated PTH level. In the kidneys, the defective CaSR leads to increased calcium reabsorption, causing marked hypocalciuria and a characteristic urine calcium-to-creatinine clearance ratio of less than 0.01. Parathyroidectomy is generally ineffective and not indicated.

Step-by-Step Solution

1
Analyze the initial serum laboratory results.
The patient has hypercalcemia with an inappropriately normal intact PTH level.
Normal physiological feedback dictates that hypercalcemia should suppress PTH secretion. An unsuppressed PTH narrows the differential to PTH-dependent causes, primarily primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH).
2
Evaluate the urine calcium indices and family history to differentiate the diagnosis.
The 24-hour urine calcium is low, the clearance ratio is less than 0.01, and there is a family history of failed parathyroidectomy.
Primary hyperparathyroidism typically presents with increased urinary calcium excretion and a clearance ratio >0.02. The combination of hypocalciuria, a low clearance ratio, and surgical failure in a first-degree relative strongly establishes the diagnosis of FHH.
3
Identify the underlying cellular mechanism of the diagnosed condition.
FHH is caused by an inactivating mutation of the calcium-sensing receptor (CaSR), which is a G protein-coupled receptor.
The mutated CaSR has decreased sensitivity to extracellular calcium, requiring higher serum calcium levels to suppress PTH secretion and leading to increased renal tubular calcium reabsorption.

Key Concept

Familial hypocalciuric hypercalcemia (FHH) is caused by an inactivating mutation of the calcium-sensing receptor (CaSR), a G protein-coupled receptor, leading to a higher set-point for calcium homeostasis.
Question 48Question →

Match each patient's clinical presentation with the precise immunopathologic mechanism responsible for their condition.

Click a left item, then click its matching right item

Items

A 23-year-old man presents with his second episode of systemic meningococcal infection despite appropriate prior antibiotic therapy.
A 35-year-old woman develops non-pitting, non-pruritic facial edema and severe colicky abdominal pain without urticaria, unresponsive to antihistamines.
A 19-year-old woman presents with a photosensitive malar rash, severe arthralgias, and proteinuria; laboratory testing reveals an undetectable CH50.
A 42-year-old man is admitted with chronic fatigue, episodic morning hematuria, and a newly diagnosed acute portal vein thrombosis.

Matches

Show answer & explanation

Answer

The first clinical vignette matches with deficient C5b-9 formation. The second matches with unregulated kallikrein activation. The third matches with defective opsonization of immune complexes. The fourth matches with absence of GPI-anchored inhibitors.
Each vignette represents a classic presentation of a complement-related immunological defect. The terminal pathway is uniquely required to fight Neisseria. The contact system's dysregulation via C1-INH deficiency causes bradykinin-mediated angioedema. The classical pathway is necessary to clear immune complexes, preventing autoimmunity. Finally, PNH is a disorder of absent complement-regulating surface proteins, leading to complement-mediated intravascular hemolysis and thrombosis.

Step-by-Step Solution

1
Identify the underlying disease for each clinical vignette.
Patient 1 has a terminal complement deficiency. Patient 2 has hereditary angioedema. Patient 3 has early complement deficiency-associated SLE. Patient 4 has paroxysmal nocturnal hemoglobinuria.
Accurate clinical diagnosis is required to link the presentation to the underlying foundational science mechanism.
2
Map each identified disease to its specific immunopathologic mechanism.
Terminal complement deficiency limits MAC (C5b-9) formation. Hereditary angioedema involves C1 inhibitor defect leading to excess bradykinin. Early complement deficiency prevents immune complex clearance. PNH lacks CD55/CD59 GPI anchors.
This establishes the foundational pathophysiology connecting clinical syndromes to immunologic processes.

Key Concept

Immunopathogenesis of complement system defects and regulatory protein deficiencies
Question 49Question →

A 44-year-old man presents to the oncology clinic for treatment planning of newly diagnosed metastatic colorectal cancer. He initially presented to his primary care physician with fatigue and was found to have iron deficiency anemia. A subsequent colonoscopy revealed a 3.5-cm ulcerated mass in the ascending colon, and a computed tomography scan of the abdomen and pelvis showed multiple hepatic metastases. His family history is notable for his father dying of colon cancer at age 48 and a paternal aunt who was treated for endometrial cancer at age 46.

Physical examination reveals pale conjunctivae and a palpable liver edge 3 cm below the right costal margin. Laboratory studies show a hemoglobin of 9.2 g/dL.

Biopsy of the hepatic lesion confirms metastatic adenocarcinoma. Immunohistochemical staining of the biopsy specimen demonstrates intact expression of MLH1 and PMS2 proteins, but absent expression of MSH2 and MSH6 proteins. The oncologist recommends initiating therapy with a programmed cell death protein 1 (PD-1) inhibitor.

Which of the following molecular characteristics best explains why this patient's neoplasm is highly susceptible to this specific pharmacologic therapy?

Show answer & explanation

Answer: Accumulation of frameshift mutations resulting in the robust generation of immunogenic neoantigens

Answer

Accumulation of frameshift mutations resulting in the robust generation of immunogenic neoantigens
The correct answer correctly identifies the molecular downstream effect of defective DNA mismatch repair (dMMR). In this patient with Lynch syndrome, the loss of MSH2 and MSH6 leads to a failure to correct DNA replication errors. This causes microsatellite instability (MSI), where repetitive DNA sequences accumulate frameshift mutations. These mutations translate into novel, abnormal peptide sequences known as neoantigens. The presence of numerous neoantigens makes the tumor highly visible (immunogenic) to the patient's cytotoxic T-cells. To survive, these tumors typically upregulate immune checkpoint proteins like PD-L1 to suppress the T-cell response. Administering a PD-1 inhibitor blocks this interaction, unleashing a potent, pre-existing immune response against the neoantigen-rich tumor.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and family history.
Early-onset right-sided colon cancer with a family history of colon and endometrial cancers strongly suggests Lynch syndrome.
Identifying the clinical syndrome provides the context for interpreting the molecular testing.
2
Interpret the tumor immunohistochemistry (IHC) results.
The absence of MSH2 and MSH6 proteins indicates defective DNA mismatch repair (dMMR).
IHC is the standard test to determine the functional status of mismatch repair proteins in colorectal cancer.
3
Correlate dMMR with its downstream molecular consequences.
Defective mismatch repair leads to microsatellite instability (MSI), causing numerous frameshift mutations and the production of novel, altered proteins (neoantigens).
Understanding the pathogenesis explains why these specific tumors interact differently with the immune system.
4
Determine the therapeutic rationale for using a PD-1 inhibitor.
The high burden of neoantigens makes the tumor highly immunogenic. The tumor survives by upregulating PD-L1 to exhaust T-cells; a PD-1 inhibitor blocks this evasion, allowing T-cells to attack the tumor.
Connects the underlying cellular pathology directly to the clinical management choice.

Key Concept

Tumors with mismatch repair deficiency (dMMR), such as those seen in Lynch syndrome, develop high microsatellite instability and a massive burden of frameshift-derived neoantigens. This high immunogenicity makes them exceptionally responsive to immune checkpoint inhibitors like PD-1 antibodies.
Estimated Time:1m 30s
Question 50Question →

A 32-year-old woman with severe symptomatic iron deficiency anemia is admitted to the hospital and started on a transfusion of packed red blood cells. Fifteen minutes after the transfusion is initiated, she acutely develops chills, severe lower back pain, and a feeling of impending doom. Her temperature is 39.1°C (102.4°F), blood pressure is 88/54 mm Hg, heart rate is 124/min, and respiratory rate is 24/min. Physical examination reveals flushing and diaphoresis. An acute hemolytic transfusion reaction is suspected. Arrange the following steps in the most appropriate chronological sequence for the immediate management and diagnostic workup of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue the transfusion, then maintain intravenous access with normal saline using new tubing, followed by a bedside clerical check, sending appropriate samples to the blood bank, and finally administering vasopressors if hypotension persists.
In an acute hemolytic transfusion reaction (AHTR), preformed host antibodies bind to donor red blood cells, causing robust complement activation and intravascular hemolysis. The immediate priority is to stop the offending immunologic trigger by discontinuing the transfusion. To prevent hypotension and acute kidney injury from free hemoglobin, intravenous fluids (0.9% normal saline) must be started immediately. Crucially, the old tubing must be disconnected and replaced so that residual incompatible blood is not flushed into the patient. Once stabilized, the physician must perform a bedside clerical check, as misidentification is the most common cause of AHTR. Subsequently, the blood bank is notified, and post-reaction samples (blood and urine) are sent to assess for hemolysis and perform a direct antiglobulin test (DAT). Finally, if the patient remains hypotensive despite initial fluid boluses, vasoactive medications (vasopressors) are administered as advanced supportive care.

Step-by-Step Solution

1
Recognize the clinical presentation as an acute hemolytic transfusion reaction (AHTR).
Identify that the patient's acute-onset fever, flank pain, and hypotension shortly after starting a transfusion indicate a life-threatening Type II hypersensitivity reaction.
AHTR is driven by preformed host antibodies (usually anti-A or anti-B) attacking donor red blood cells, triggering massive complement activation, intravascular hemolysis, and systemic cytokine release.
2
Prioritize immediate interventions to halt the immunologic trigger and stabilize hemodynamics.
Determine that stopping the transfusion and replacing the intravenous tubing to infuse normal saline are the absolute critical first steps.
Limiting antigen exposure is the most important intervention to halt the hypersensitivity cascade. Using new tubing prevents inadvertently flushing residual incompatible blood into the patient.
3
Sequence the subsequent diagnostic and supportive management steps.
Place the bedside clerical check before laboratory notification and sample collection, with advanced supportive care (vasopressors) reserved for refractory instability.
A clerical error is the most common cause of AHTR and must be checked immediately. Laboratory tests confirm the diagnosis, and pressors are a secondary intervention for fluid-refractory shock.

Key Concept

The management of an acute hemolytic transfusion reaction (a Type II hypersensitivity response) prioritizes immediately halting the transfusion, maintaining hemodynamic stability with normal saline via new tubing, and aggressively investigating the cause, starting with a bedside clerical check.
Question 51Question →

Match each patient's clinical presentation with the primary molecular mechanism of immune evasion or pathogenesis utilized by the causative organism.

Click a left item, then click its matching right item

Items

A 32-year-old pregnant woman presents with fever and myalgias after consuming unpasteurized cheese; blood cultures grow Gram-positive, non-spore-forming bacilli exhibiting tumbling motility at room temperature.
A 24-year-old man treated successfully for purulent urethritis three months ago returns with an identical presentation; urethral swab demonstrates intracellular Gram-negative diplococci.
A 45-year-old man receiving hemodialysis via a tunneled catheter develops acute endocarditis; blood cultures rapidly grow coagulase-positive, Gram-positive cocci in clusters.
A 62-year-old man with a history of prolonged incarceration presents with chronic cough, night sweats, and apical cavitary lung disease; sputum smear reveals acid-fast bacilli.

Matches

Show answer & explanation

Answer

The correct pairings are: the pregnant woman with Listeria matches phagosomal escape via cytolysin; the man with recurrent gonorrhea matches continuous alteration of surface appendages via recombination; the hemodialysis patient with Staphylococcus aureus matches binding of the IgG Fc region; and the incarcerated man with tuberculosis matches the inhibition of phagolysosome maturation.
Each pairing correctly maps a clinical scenario to the foundational virulence mechanism of the responsible pathogen. The pregnant patient with a Gram-positive motile rod is infected with Listeria monocytogenes, which uses listeriolysin O to form pores and escape the phagosome. The young man with recurrent gonorrhea lacks protective immunity because Neisseria gonorrhoeae constantly varies its pilin proteins via homologous recombination. The hemodialysis patient with coagulase-positive Staphylococcus aureus bacteremia suffers from an infection facilitated by Protein A, which binds the Fc portion of IgG to block complement activation and opsonization. Finally, the man with cavitary tuberculosis is infected by Mycobacterium tuberculosis, an organism that uses sulfatides and cord factor to inhibit EEA1, preventing phagolysosome fusion and allowing intracellular survival.

Step-by-Step Solution

1
Identify the causative organism for each clinical vignette based on the provided history and microbiological findings.
The pathogens are Listeria monocytogenes (pregnant, unpasteurized cheese, tumbling motility), Neisseria gonorrhoeae (recurrent urethritis, intracellular diplococci), Staphylococcus aureus (catheter, coagulase-positive clusters), and Mycobacterium tuberculosis (incarceration, cavitary lesions, acid-fast bacilli).
Accurate identification of the underlying pathogen is a prerequisite for determining its specific virulence and immune evasion mechanism.
2
Determine the primary mechanism of immune evasion or pathogenesis for each identified organism.
Listeria escapes the phagosome; Neisseria alters its pili; S. aureus binds IgG via Protein A; M. tuberculosis inhibits phagolysosome fusion.
This links the foundational microbiological science to the clinical presentation, satisfying the core objective.
3
Match the pathogen's conceptual mechanism to the highly descriptive molecular text provided in the options.
Listeria pairs with cholesterol-dependent cytolysin (listeriolysin O); Neisseria pairs with homologous recombination; S. aureus pairs with surface polypeptide binding the Fc region; M. tuberculosis pairs with cell-wall glycolipids inhibiting endosomal autoantigen 1.
This completes the matching requirement by translating standard terminology into advanced molecular descriptions.

Key Concept

Successful human pathogens utilize highly specific molecular mechanisms to evade the immune system, such as escaping the phagosome (Listeria), varying surface antigens to prevent protective immunity (Neisseria), neutralizing opsonizing antibodies (Staphylococcus), and arresting intracellular clearance pathways (Mycobacterium).
Estimated Time:1m 30s
Question 52Question →

Correlate each infectious disease scenario with the specific cellular mechanism of its causative bacterial toxin.

Click a left item, then click its matching right item

Items

A 7-year-old child with no vaccination history presents with profound weakness and a grayish exudate over the tonsils.
A 45-year-old man exhibits dysarthria, blurred vision, and symmetric descending weakness after eating home-preserved vegetables.
A 32-year-old aid worker develops massive volumes of 'rice-water' diarrhea leading to severe dehydration without fever.
A 55-year-old farmer experiences severe facial muscle spasms and jaw stiffness days after stepping on a rusty nail.
A 22-year-old woman develops a sudden high fever, diffuse macular rash, and hypotension associated with retained nasal packing.

Matches

Show answer & explanation

Answer

The correct matches pair each clinical syndrome with the distinct molecular action of its causative bacterial exotoxin: Diphtheria with EF-2 inhibition; Botulism with peripheral SNARE cleavage; Cholera with Gs-alpha activation; Tetanus with central SNARE cleavage; and Toxic Shock Syndrome with MHC-II/TCR cross-linking.
Each pathogen utilizes a distinct exotoxin with a specific molecular target. Diphtheria toxin ADP-ribosylates EF-2. Botulinum toxin cleaves SNARE proteins at the peripheral neuromuscular junction. Cholera toxin ADP-ribosylates Gs-alpha. Tetanus toxin cleaves SNARE proteins in central inhibitory interneurons. TSST-1 acts as a superantigen by cross-linking MHC-II and the T-cell receptor.

Step-by-Step Solution

1
Analyze the clinical presentation of the 7-year-old with an unimmunized status and tonsillar exudate.
Identify the pathogen as Corynebacterium diphtheriae.
The grayish pharyngeal pseudomembrane and lack of immunization are classic for diphtheria.
2
Analyze the presentation of descending flaccid paralysis after eating home-preserved goods.
Identify the pathogen as Clostridium botulinum.
Botulism classically presents with cranial nerve palsies descending to symmetric flaccid weakness.
3
Analyze the presentation of painless, profuse watery diarrhea in an aid worker.
Identify the pathogen as Vibrio cholerae.
Cholera is characterized by voluminous 'rice-water' stools without significant inflammatory signs like fever.
4
Analyze the presentation of jaw stiffness and spastic paralysis after a puncture wound.
Identify the pathogen as Clostridium tetani.
Tetanus classically causes trismus (lockjaw) and generalized painful muscle spasms.
5
Analyze the presentation of sudden fever, rash, and hypotension associated with retained nasal packing.
Identify the pathogen as Staphylococcus aureus.
This is a classic presentation of Staphylococcal toxic shock syndrome, which can be triggered by retained foreign bodies like tampons or nasal packing.
6
Map each identified pathogen to its specific toxin mechanism.
Diphtheria = EF-2 ADP-ribosylation; Botulinum = peripheral SNARE cleavage; Cholera = Gs-alpha ADP-ribosylation; Tetanus = central SNARE cleavage; S. aureus = superantigen cross-linking.
Connecting the clinical syndrome to the foundational molecular mechanism demonstrates mastery of infectious disease pathogenesis.

Key Concept

Bacterial exotoxins utilize specific molecular mechanisms, such as ADP-ribosylation, SNARE protein cleavage, and superantigen activity, to disrupt normal host cell function and cause characteristic clinical syndromes.
Question 53Question →

Match each clinical scenario describing a patient with an advanced malignancy who has developed acquired resistance to a targeted antineoplastic therapy with the most likely underlying molecular mechanism of resistance.

Click a left item, then click its matching right item

Items

A 62-year-old woman with metastatic non-small cell lung cancer harboring an EGFR exon 19 deletion progresses with new brain metastases after 18 months of initial therapy with osimertinib.
A 45-year-old man with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase develops progressive leukocytosis and early blast crisis after 2 years on imatinib.
A 59-year-old man with metastatic BRAF V600E-mutated cutaneous melanoma develops new hepatic metastases after initially achieving a dramatic response to vemurafenib monotherapy.
A 70-year-old man with metastatic castration-resistant prostate cancer develops worsening bone pain and a rapidly rising PSA level after 10 months of treatment with abiraterone acetate.

Matches

Show answer & explanation

Answer

NSCLC/osimertinib resistance matches with C797S mutation or MET amplification. CML/imatinib resistance matches with the T315I gatekeeper mutation. Melanoma/vemurafenib resistance matches with MAPK reactivation via NRAS mutation or target amplification. Prostate cancer/abiraterone resistance matches with truncated steroid receptor splice variants.
Each class of targeted therapy exerts specific selective pressure on tumor cells, leading to predictable molecular mechanisms of resistance. Recognizing these patterns is essential for sequencing next-line therapies. Osimertinib resistance occurs via C797S or bypass tracks. Imatinib resistance is driven by the T315I gatekeeper mutation. Vemurafenib resistance involves paradoxical MAPK pathway reactivation. Abiraterone resistance involves androgen receptor modifications like AR-V7.

Step-by-Step Solution

1
Analyze the non-small cell lung cancer scenario on osimertinib.
Matches with C797S mutation or MET amplification.
Osimertinib relies on covalent binding to mutated EGFR; the C797S mutation directly disrupts this binding. Alternatively, the tumor bypasses EGFR completely via MET amplification.
2
Analyze the chronic myeloid leukemia scenario on imatinib.
Matches with the T315I gatekeeper missense mutation.
T315I is the classic structural alteration in the ABL kinase domain that blocks imatinib binding, necessitating salvage therapy with ponatinib or asciminib.
3
Analyze the melanoma scenario on vemurafenib.
Matches with reactivation of the downstream MAPK signaling cascade.
Melanoma cells overcome isolated BRAF inhibition by upregulating alternative pathway components (like NRAS), driving ERK signaling independent of the inhibited BRAF.
4
Analyze the prostate cancer scenario on abiraterone acetate.
Matches with expression of a truncated steroid receptor splice variant.
Abiraterone works by systemic androgen depletion; the tumor adapts by expressing an androgen receptor variant (AR-V7) that activates transcription even in the absence of androgen ligands.

Key Concept

Molecular mechanisms of acquired resistance to targeted antineoplastic therapies
Question 54Question →

Match each patient's clinical presentation and advanced hemostatic laboratory findings with the correct underlying pathophysiological mechanism of their coagulation disorder.

Click a left item, then click its matching right item

Items

A 68-year-old female presents with spontaneous, extensive ecchymoses. Labs show an isolated prolonged aPTT. A 1:1 mixing study with normal plasma shows complete immediate correction, but the aPTT re-prolongs significantly after 2 hours of incubation at 37°C.
A 29-year-old female with a history of recurrent mid-trimester fetal loss presents with deep vein thrombosis. Labs show an isolated prolonged aPTT. A 1:1 mixing study demonstrates no correction of the aPTT immediately or after incubation.
A 35-year-old asymptomatic male is evaluated prior to a tonsillectomy. Labs reveal an isolated prolonged aPTT. A 1:1 mixing study demonstrates complete correction of the aPTT immediately, and the correction is maintained after 2 hours of incubation.
A 22-year-old female presents with severe menorrhagia and borderline thrombocytopenia. Her PT and aPTT are normal. Platelet aggregometry demonstrates an enhanced aggregation response to low-dose ristocetin.

Matches

Show answer & explanation

Answer

The correct pairings match the time-dependent inhibitor presentation with Acquired Hemophilia A, the immediate inhibitor presentation with Lupus Anticoagulant, the sustained correction presentation with Factor XI deficiency, and the enhanced low-dose ristocetin response with Type 2B von Willebrand disease.
Each advanced laboratory finding corresponds uniquely to a specific pathophysiological mechanism. Time-dependent mixing study correction failures are driven by Factor VIII autoantibodies. Immediate mixing study failures in pro-thrombotic patients are driven by antiphospholipid antibodies. Complete, sustained mixing study corrections represent true zymogen deficiencies. Enhanced low-dose ristocetin responses point directly to the hyper-affinity glycoprotein defect of Type 2B vWD.

Step-by-Step Solution

1
Analyze the immediate vs. incubated mixing study results to differentiate factor deficiencies from specific inhibitors.
Sustained correction indicates a factor deficiency. Immediate failure to correct indicates an immediate inhibitor. Initial correction followed by failure after 2 hours indicates a time-dependent inhibitor.
Normal plasma provides 50% factor levels, correcting a deficiency. Immediate inhibitors (like lupus anticoagulant) neutralize immediately, while Factor VIII autoantibodies require incubation at physiological temperatures to fully neutralize the factor in vitro.
2
Differentiate the clinical consequences of the specific inhibitors.
The immediate inhibitor (lupus anticoagulant) is paradoxically pro-thrombotic in vivo, explaining the recurrent fetal loss and DVT. The time-dependent inhibitor (Acquired Hemophilia A) causes severe spontaneous bleeding.
Lupus anticoagulants target phospholipid-binding proteins, causing endothelial activation in vivo. Factor VIII autoantibodies completely disrupt the intrinsic tenase complex, severely impairing in vivo hemostasis.
3
Interpret the specialized platelet aggregometry combined with the clinical presentation.
Normal coagulation times combined with thrombocytopenia and enhanced low-dose ristocetin-induced platelet aggregation (RIPA) definitively identifies Type 2B von Willebrand disease.
Unlike standard vWD which shows reduced RIPA, Type 2B involves a gain-of-function mutation. The mutant vWF spontaneously binds platelets in vivo, clearing them from circulation (causing thrombocytopenia) and reacting aggressively to even trace amounts of ristocetin in vitro.

Key Concept

Interpretation of immediate vs. incubated mixing studies and platelet aggregometry to diagnose complex coagulopathies.
Question 55Question →

A 28-year-old primigravida at 14 weeks gestation is brought to the emergency department by her husband due to progressive confusion, lethargy, and recurrent vomiting over the past 24 hours. The husband reports that her symptoms began shortly after they attended a celebratory dinner where she consumed a large portion of steak. The patient has a lifelong history of self-restricting meat and dairy from her diet, stating they make her feel "foggy and irritable." Family history is notable for a male sibling who died at 4 days of life from a "metabolic coma."

Physical examination reveals a somnolent woman who arouses to physical stimuli. She exhibits a flapping tremor of the hands when her wrists are extended.

Laboratory studies are as follows:

TestResultReference Range
Sodium140 mEq/L136-145 mEq/L
Potassium4.1 mEq/L3.5-5.0 mEq/L
Chloride104 mEq/L95-105 mEq/L
Bicarbonate24 mEq/L22-28 mEq/L
Blood urea nitrogen (BUN)4 mg/dL7-18 mg/dL
Creatinine0.6 mg/dL0.6-1.2 mg/dL
Glucose98 mg/dL70-99 mg/dL
Arterial pH7.497.35-7.45
PaCO2PaCO_228 mm Hg35-45 mm Hg
Serum ammonia280 μmol/L15-45 μmol/L

Urinalysis reveals markedly elevated orotic acid levels.

Which of the following genetic principles best explains why this patient survived to adulthood while her sibling experienced early neonatal mortality?

Show answer & explanation

Answer: Asymmetric epigenetic silencing of a sex chromosome during early embryogenesis

Answer

Asymmetric epigenetic silencing of a sex chromosome during early embryogenesis
The patient is experiencing an acute hyperammonemic crisis secondary to ornithine transcarbamylase (OTC) deficiency, which has been unmasked by the physiologic stress of pregnancy and a high-protein meal. OTC deficiency is the only urea cycle disorder with an X-linked recessive inheritance pattern. Males (hemizygous) typically present with severe, often fatal, neonatal hyperammonemia, consistent with the patient's deceased brother. Female carriers (heterozygous) have a highly variable clinical phenotype ranging from asymptomatic to severe adult-onset crises. This variability is driven by skewed X-chromosome inactivation (lyonization) in hepatocytes—a process of asymmetric epigenetic silencing via DNA methylation and heterochromatin formation during early embryogenesis. If by chance the normal X chromosome is preferentially inactivated in a majority of liver cells, the female carrier will exhibit limited enzyme activity and become symptomatic under nitrogen load.

Step-by-Step Solution

1
Analyze the patient's laboratory profile and clinical presentation.
The patient has hyperammonemia, low BUN, respiratory alkalosis, and highly elevated urinary orotic acid in the setting of acute encephalopathy triggered by a high-protein meal.
These specific biochemical markers distinguish urea cycle defects from other metabolic causes of altered mental status.
2
Diagnose the specific underlying metabolic disorder.
The combination of hyperammonemia and elevated orotic acid confirms ornithine transcarbamylase (OTC) deficiency.
OTC deficiency prevents the conversion of carbamoyl phosphate and ornithine to citrulline. The accumulated carbamoyl phosphate shunts into the pyrimidine synthesis pathway, producing excess orotic acid. Other urea cycle defects (like CPS1 deficiency) present with low orotic acid.
3
Determine the genetic inheritance pattern of the identified disorder.
OTC deficiency is uniquely inherited in an X-linked recessive pattern.
Unlike all other urea cycle defects, which are autosomal recessive, OTC is X-linked. This explains the family history of a male sibling suffering lethal neonatal metabolic coma (hemizygous).
4
Identify the molecular mechanism allowing the female patient to survive to adulthood but become symptomatic under stress.
The correct mechanism is asymmetric epigenetic silencing of the X chromosome, clinically known as skewed X-inactivation or lyonization.
In heterozygous females, random X-inactivation occurs. If a disproportionately large number of normal X chromosomes are inactivated in the liver, the female will manifest symptoms of the X-linked recessive disorder, particularly when exposed to increased metabolic demand (e.g., pregnancy, high-protein diet).

Key Concept

Ornithine transcarbamylase (OTC) deficiency presentation in female carriers is dependent on the degree of skewed X-chromosome inactivation (lyonization).
Question 56Question →

A medical geneticist is reviewing the charts of several adult and pediatric patients with complex genetic presentations. To finalize their diagnostic formulations and targeted management plans, match each patient's clinical presentation and preliminary genetic findings to the precise underlying molecular or targeted therapeutic mechanism.

Click a left item, then click its matching right item

Items

An adult female with endometrial adenocarcinoma demonstrates isolated loss of MSH2 and MSH6 on immunohistochemistry, but genomic sequencing reveals no pathogenic sequence variants within the coding regions of either mismatch repair gene.
A male patient in his mid-thirties develops progressive gait ataxia. His father developed similar symptoms at age 62, reflecting a phenomenon driven by meiotic instability of a specific pathogenic allele.
An infant with profound hypotonia and areflexia secondary to a homozygous SMN1 deletion is successfully stabilized using an intrathecally administered molecular therapy.
An asymptomatic couple seeking preconception counseling is found to carry two completely different pathogenic variants in the CFTR gene, raising questions about predicting their offspring's specific pulmonary and pancreatic phenotype.
A young adult male experiences subacute, painless bilateral central vision loss. His maternal uncle suffered a similar fate, while his mother only has mild, subclinical color vision abnormalities.

Matches

Show answer & explanation

Answer

The correct matches require linking the clinical phenotype and test results to their advanced molecular mechanisms: MSH2 loss without coding mutation matches EPCAM-induced hypermethylation; progressive ataxia with anticipation matches expansion bias during spermatogenesis; hypotonia treated with targeted therapy matches alteration of SMN2 alternative splicing; inheritance of two distinct CFTR mutations matches compound heterozygosity; and maternally inherited vision loss with variable severity matches stochastic distribution of extranuclear genomes (heteroplasmy).
Each correct pairing directly connects a complex clinical presentation to a high-yield, advanced molecular mechanism. Recognizing that EPCAM deletions epigenetically silence MSH2, that CAG repeats undergo massive expansion during spermatogenesis, that nusinersen alters SMN2 splicing, that two different variants in one gene constitute compound heterozygosity, and that mitochondrial disease severity relies on heteroplasmy are all essential competencies for diagnostic evaluation and patient counseling at the independent practitioner level.

Step-by-Step Solution

1
Analyze the mismatch repair deficiency case (endometrial cancer with absent MSH2/MSH6).
Identify that absent protein expression without a coding mutation strongly points to epigenetic silencing, classically via upstream EPCAM deletion.
This establishes the mechanism for EPCAM-associated Lynch syndrome.
2
Analyze the progressive ataxia case demonstrating anticipation across generations.
Identify that CAG repeat disorders exhibit anticipation heavily biased toward paternal transmission due to instability during spermatogenesis.
This distinguishes polyglutamine repeat expansions from those occurring in oogenesis (like Fragile X).
3
Analyze the infant hypotonia case (SMA) receiving intrathecal therapy.
Recognize that targeted therapy for SMN1 deletion (nusinersen) modulates pre-mRNA splicing of the SMN2 paralog.
This links a modern pharmacogenomic intervention to its precise molecular mechanism of action.
4
Analyze the preconception counseling case involving cystic fibrosis.
Recognize that inheriting two completely distinct mutations in the same gene represents compound heterozygosity.
This explains why patients with the same disease may have vastly different phenotypic severities based on residual allelic function.
5
Analyze the vision loss case showing a maternal inheritance pattern with variable penetrance.
Link the variable expressivity among maternal relatives to mitochondrial heteroplasmy (random segregation of mutated mitochondrial genomes).
This explains the hallmark feature of mitochondrial disorders known as the threshold effect.

Key Concept

Advanced molecular diagnostics and targeted pharmacogenomics often rely on identifying mechanisms beyond simple Mendelian inheritance, including epigenetic silencing (EPCAM/MSH2), expansion bias during specific gametogenesis (CAG repeats in spermatogenesis), alternative splicing modulation (SMA therapy), compound heterozygosity, and mitochondrial heteroplasmy.
Question 57Question →

Match each bacterial pathogen's primary virulence toxin with its precise molecular mechanism of action.

Click a left item, then click its matching right item

Items

Corynebacterium diphtheriae exotoxin
Vibrio cholerae enterotoxin
Clostridium tetani neurotoxin
Staphylococcus aureus TSST-1

Matches

Show answer & explanation

Answer

The correct matches align specific bacterial toxins with their cellular targets: Corynebacterium diphtheriae exotoxin inactivates EF-2, Vibrio cholerae enterotoxin ADP-ribosylates Gs protein, Clostridium tetani neurotoxin cleaves SNARE proteins, and Staphylococcus aureus TSST-1 cross-links TCR to MHC class II.
Each exotoxin has a highly specific cellular target that dictates its pathophysiology. Diphtheria toxin halts protein synthesis via EF-2 inactivation, causing pseudomembrane formation. Cholera toxin perpetually activates adenylate cyclase by targeting Gs, leading to secretory diarrhea. Tetanospasmin prevents the release of GABA and glycine by cleaving SNARE proteins, resulting in spastic paralysis. TSST-1 is a superantigen that bridges MHC class II and T-cell receptors without specific antigen processing, leading to toxic shock syndrome.

Step-by-Step Solution

1
Identify the pathogen and its associated major virulence factor.
The four bacterial toxins listed are classic, well-characterized exotoxins associated with specific clinical syndromes.
Pathogen and toxin identification is the necessary first step in determining the underlying pathogenesis.
2
Recall the cellular target or molecular mechanism for each specific toxin.
Diphtheria toxin targets EF-2, cholera toxin targets Gs protein, tetanospasmin targets SNARE proteins, and TSST-1 acts as a superantigen.
Matching the molecular mechanism directly explains the distinct clinical manifestations of each bacterial infection.

Key Concept

Bacterial Exotoxin Mechanisms
Question 58Question →

A 28-year-old aid worker presents to a field clinic with severe, voluminous watery diarrhea and leg cramps. The responsible pathogen produces an AB-type exotoxin that causes profound fluid loss. Arrange the following steps of this toxin's cellular mechanism of action in the correct pathophysiological sequence, from initial interaction with the host cell to the ultimate physiologic effect.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of Vibrio cholerae toxin action is: 1) Binding to GM1 ganglioside, 2) Internalization of the A subunit, 3) ADP-ribosylation of the Gs protein, 4) Activation of adenylate cyclase causing increased cAMP, and 5) Activation of PKA leading to CFTR channel opening and secretory diarrhea.
The pathogenesis of Vibrio cholerae relies on its AB exotoxin. The B (binding) subunit attaches to GM1 ganglioside receptors on intestinal epithelial cells. Once endocytosed, the active A subunit escapes into the cytosol where it catalyzes the ADP-ribosylation of the Gs alpha subunit. This modification locks Gs in an active state, causing continuous stimulation of adenylate cyclase and a massive increase in intracellular cAMP. Elevated cAMP activates protein kinase A, which phosphorylates and opens the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) channel. The resulting massive efflux of chloride ions into the intestinal lumen is followed by sodium and water, producing the characteristic severe secretory diarrhea.

Step-by-Step Solution

1
Identify the clinical syndrome and pathogen.
The presentation of severe, voluminous watery diarrhea (rice-water stools) in an aid worker points to cholera, caused by Vibrio cholerae.
Recognizing the pathogen dictates which specific AB toxin mechanism is being tested.
2
Determine the initial host-pathogen interaction.
The sequence begins with the binding of the toxin's B subunit to the GM1 ganglioside receptor.
Exotoxins must attach to specific host cell receptors before they can exert intracellular effects.
3
Trace the intracellular enzymatic cascade.
After internalization, the A subunit ADP-ribosylates the Gs protein, which turns on adenylate cyclase and increases cAMP.
This is the hallmark molecular mechanism of cholera toxin, distinguishing it from other AB toxins.
4
Identify the final cellular consequence.
Elevated cAMP activates PKA, which opens the CFTR chloride channel, dragging water into the lumen.
This terminal step directly explains the profound watery diarrhea seen in the patient.

Key Concept

Cholera toxin mechanism of action
Question 59Question →

A 45-year-old man undergoes a right hemicolectomy for a colon adenocarcinoma. His family history is notable for a father who died of colorectal cancer at age 49 and a sister diagnosed with endometrial cancer at age 46. The physician suspects Lynch syndrome and plans a comprehensive molecular and genetic evaluation.

Assuming this patient's cancer is ultimately found to be caused by a germline mutation in the MLH1 gene, arrange the following diagnostic and management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Tumor IHC/MSI testing -> Tumor BRAF/MLH1 methylation testing -> Germline MLH1 sequencing -> Cascade testing of relatives.
The correct sequence follows the standard molecular diagnostic algorithm for Lynch syndrome. Initial evaluation begins with tumor tissue screening via immunohistochemistry (IHC) or microsatellite instability (MSI) testing. Because loss of MLH1 is frequently caused by sporadic somatic hypermethylation of the MLH1 promoter (often correlated with a BRAF V600E mutation), tumor tissue must be tested for these somatic markers to rule out sporadic disease. Once a sporadic etiology is excluded, a peripheral blood sample is used for germline sequencing of the specific mismatch repair gene to confirm the hereditary diagnosis. Only after a specific pathogenic germline variant is definitively identified in the index patient can targeted predictive cascade testing be offered to at-risk family members.

Step-by-Step Solution

1
Determine the initial screening test for a suspected hereditary cancer syndrome when tumor tissue is available.
Tumor immunohistochemistry (IHC) or microsatellite instability (MSI) testing is indicated.
Tumor screening identifies if the mismatch repair pathway is defective and which specific protein is involved, guiding further testing.
2
Identify the next step if MLH1 expression is lost on IHC.
Test the tumor for BRAF V600E mutation and MLH1 promoter hypermethylation.
Loss of MLH1 is most commonly due to sporadic somatic promoter hypermethylation. Testing for this (and the associated BRAF mutation) differentiates sporadic cases from true suspected Lynch syndrome.
3
Select the appropriate test to confirm the hereditary diagnosis once sporadic causes are ruled out.
Germline sequencing and deletion/duplication analysis of the MLH1 gene from a blood sample.
Germline testing confirms the presence of an inherited pathogenic variant, establishing the diagnosis of Lynch syndrome.
4
Determine the management of family members after a germline mutation is confirmed.
Targeted predictive cascade testing for the specific variant in first-degree relatives.
Once the familial mutation is known, relatives can be tested for that specific variant to determine their cancer risk and screening needs.

Key Concept

The diagnostic algorithm for Lynch syndrome requires sequential molecular testing: initial tumor screening (IHC/MSI), exclusion of sporadic causes (BRAF/methylation if MLH1 is absent), confirmatory germline sequencing, and finally, targeted cascade testing for at-risk relatives.
Estimated Time:1m 30s
Question 60Question →

A 24-year-old woman is brought to the emergency department 36 hours after intentionally ingesting a massive quantity of an unknown over-the-counter analgesic. She is visibly jaundiced and lethargic. Laboratory studies show an aspartate aminotransferase (AST) of 8,500 U/L, an alanine aminotransferase (ALT) of 9,200 U/L, and a significantly prolonged prothrombin time. A subsequent liver biopsy reveals massive centrilobular (Zone 3) parenchymal necrosis. Based on the patient's presentation, arrange the following subcellular biochemical events in the correct chronological sequence that culminated in this patient's hepatocyte injury.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Exhaustion of intracellular sulfhydryl-group donors -> Unopposed covalent binding of electrophilic intermediates -> Oxidative stress-induced lipid peroxidation -> Irreversible opening of the MPTP -> Efflux of cytochrome c into the cytosol.
The correct chronological progression of acetaminophen-induced hepatocellular injury begins with the depletion of protective glutathione reserves, allowing the toxic metabolite NAPQI to bind to cellular proteins. This covalent binding disrupts mitochondrial function, causing severe oxidative stress and lipid peroxidation. The resulting membrane damage triggers the irreversible opening of the mitochondrial permeability transition pore (MPTP), dissipating the mitochondrial proton gradient. Finally, this loss of integrity leads to the release of cytochrome c into the cytosol, sealing the cell's fate through both ATP-depletion necrosis and caspase-mediated apoptosis.

Step-by-Step Solution

1
Diagnose the clinical syndrome based on the patient's presentation, laboratory values, and histological findings.
The extreme elevation of transaminases (AST/ALT in the thousands), acute coagulopathy, jaundice, and Zone 3 necrosis following an intentional analgesic overdose strongly indicate fulminant acetaminophen-induced hepatotoxicity.
Establishing the specific etiology of the injury is required to accurately identify the specific downstream pathophysiologic cellular mechanism.
2
Identify the primary molecular initiator of cellular injury in this specific toxicity model.
Acetaminophen overdose saturates normal non-toxic conjugation pathways, generating the toxic metabolite NAPQI via the CYP450 system. NAPQI immediately depletes glutathione (intracellular sulfhydryl donors).
Cellular antioxidant defenses must be exhausted before structural macromolecular injury can proceed.
3
Trace the consequence of unmitigated toxic metabolites on cellular structures.
Without glutathione, NAPQI covalently binds to cellular and mitochondrial proteins, disrupting normal mitochondrial respiration and generating reactive oxygen species (ROS) which cause lipid peroxidation.
This establishes the transition from isolated biochemical toxicity to widespread structural organelle damage.
4
Determine the final lethal mitochondrial events that execute cell death.
The extensive oxidative damage triggers the opening of the mitochondrial permeability transition pore (MPTP). The resulting loss of the proton gradient forces mitochondrial swelling, outer membrane rupture, and the release of cytochrome c to execute apoptosis and necrosis.
Understanding the terminal phase of irreversible cell injury requires linking membrane damage to the cessation of ATP synthesis and activation of executioner cascades.

Key Concept

The sequential subcellular mechanisms of chemically induced cellular injury, specifically culminating in mitochondrial dysfunction and membrane damage.
PreviousPage 3 / 22Next
Foundational Science and Mechanisms of Disease Practice Questions — USMLE Step 3 — Page 3 | Examkin